A new energy field. A new frontier for molecules. Precision molecular regulation through natural forces alone — no solvents, no reagents.
Developed by the HPERA Research Facility · AIAU Lab
At the frontier of biophysics, HPERA has discovered a fundamentally new class of energy field — the Small Molecule Biofield — opening an unprecedented pathway for precise control at the molecular scale.
This discovery does not rely on chemical reagents, catalysts, or solvents. Instead, it harnesses a natural energetic phenomenon that interacts directly with molecular bonds, enabling cleavage and reformation with a fidelity that conventional chemistry cannot match.
The lab has also independently developed the world's first device capable of generating this field — the Peptides Small Molecule Field Generator (PSMFG) — translating a fundamental discovery into a working technology platform.
The Small Molecule Biofield exerts a directed energetic influence at the molecular scale, enabling the precise cleavage and reformation of chemical bonds.
Within this field, molecular structures can be disassembled and reconstructed with a fidelity that conventional chemistry cannot match. The process is driven entirely by natural field forces — no synthetic intervention required.
The field operates without chemical solvents. Molecules are reshaped through natural force alone, producing clean output suitable for direct biological application.
The two most mysterious and dominant constituents of the universe — invisible, undetectable directly, yet governing cosmic evolution. HPERA bridges these deep cosmic forces with molecular-level biotechnological application.
Dark matter neither emits nor reflects light, yet holds galaxies together through gravity. Like an invisible cosmic skeleton, it provides the structural framework upon which the visible universe is built.
85% of all matter in the cosmos
An even more enigmatic force, dark energy drives the accelerating expansion of the universe — behaving like a ubiquitous, all-pervading form of anti-gravity that pushes space itself apart.
68% of the universe's total energy
Neither can be seen or directly detected — yet together they govern the evolution of the universe. Understanding their nature is the core frontier of contemporary physics and cosmology.
HPERA continues to push the boundaries of spatial bio-intelligence, achieving a breakthrough by introducing dark matter and dark energy into biological substrate interaction experiments.
Independently researched, designed, and built by HPERA, the PSMFG is the world's first device capable of generating and sustaining a Small Molecule Biofield — the convergence of frontier physics and precision engineering.
The PSMFG harnesses dark matter and dark energy, unfolding them through Planck-scale operations in higher-dimensional space to excite and generate the Small Molecule Biofield.
Within the field it produces, small-molecule peptides and lysozyme are extracted — without chemical solvents, without harming any living organism.
The HPERA Research Facility · AIAU Lab, where the Peptides Small Molecule Field Generator operates — bridging dark matter physics, molecular biology, and precision engineering under one roof.
Beyond demonstrated peptide and lysozyme synthesis, the Small Molecule Biofield enables broad molecular structure reconfiguration — a platform technology, not a single-purpose tool.
Chemical bonds broken and reconstituted through natural field forces alone. No solvents, no catalysts, no synthetic reagents — and no harm to living organisms.
Molecular-level control with broad applicability — from targeted bond cleavage to full structural reconfiguration across diverse molecular species.
Products — peptides, lysozyme, and beyond — emerge in biologically compatible form, free from chemical residue or contamination.
Not a single-purpose tool — a foundational platform whose molecular reconfiguration capability extends across compound classes.
A fundamentally new modality of control at the atomic scale — solvent-free, biocompatible, and broadly applicable across industries.
Precision synthesis of bioactive molecules, enzyme production, and targeted molecular therapies — all without chemical interference or contamination.
De novo design and fabrication of novel materials through molecular engineering enabled by field-driven bond reconfiguration.
Alternative pathways for energy conversion and storage at the molecular scale, leveraging the field's unique interaction with matter.
A new technological foundation for the broad health industry — from bioactive supplements to regenerative applications — with solvent-free, biocompatible production.
The Small Molecule Biofield is not an incremental improvement. It is a platform discovery — a new layer of nature that HPERA is the first to discover and harness, from fundamental science through to working instrumentation.